A similar observation was made with cationic liposomes encapsulating α-GalCer and peptide antigen tyrosine-related protein 2 (TRP2), where anti-tumour responses were only observed when the liposomes were administered intravenously [107]. The gene discussed is DCT; the disease is neoplasm.